*For medical professionals only
Here, you can obtain exciting content such as cutting-edge progress in the field of ophthalmology, guideline interpretation, case analysis, etc., and easily obtain the latest, hottest, and most clinical knowledge!
On March 21, 2022, the “Medical Ophthalmology Channel” was officially launched!
As a leading medical media platform in the industry, since its establishment in 2012, “Medical World” has always adhered to “serving doctors and improving medical care”. At present, the medical community has 26+ academic sub-channels. , WeChat public account matrix has over 10 million subscribers, and the “Medical Doctor Station” APP has over 2.5 million registered users.
The launch of the “Medical Ophthalmology Channel” means that we will gather more colleagues who are engaged in ophthalmology-related work here to learn and grow together.
Why did we choose ophthalmology this time?
In China, eye diseases have a large patient population and the prevalence is still increasing. By the end of 2020, the prevalence of myopia in the population over 5 years old has risen to 51%, and the number of myopia patients has risen rapidly to 710 million; the common eye diseases in middle-aged and elderly people are mainly cataract, macular degeneration and dry eye, and the estimated patient population corresponds to 1.7 100 million, 64 million and 80 million.
With the deepening of aging, increased work intensity, lifestyle changes, increased allergens, and improper eye use, cataract, glaucoma, dry eye, keratoconjunctivitis, The incidence of various eye diseases such as corneal injury ulcers and video terminal syndrome is increasing year by year.
Secondly, the standardized diagnosis and treatment of ophthalmic diseases in my country still needs further development.
According to Professor Li Dyan, Vice President of the First People’s Hospital of Xuzhou City, Jiangsu Province, the proposal during the “two sessions” was introduced. Taking the diagnosis and treatment of fundus diseases as an example, there are currently more than 40 million patients in my country. The total number of patients with fundus diseases ranks first in the world, covering age-related macular degeneration, diabetic retinopathy, choroidal neovascularization, retinal vein occlusion and other clinical diseases.
However, the actual diagnosis and treatment rate of fundus patients in my country is very low, with an average standard treatment rate of less than 20%.
Investigating the reasons, the diagnosis and treatment of fundus diseases in my country presents two characteristics:
The public’s awareness of fundus diseases is low, and the awareness of early screening is not strong. In particular, the early screening of high-risk groups such as premature infants, three high-risk groups (hypertension, high blood sugar, and high blood lipids), the elderly, and high myopia is not timely enough, which makes it difficult for patients to receive regular and timely treatment during the golden period of treatment, which affects the therapeutic effect.
The medical resources and clinical capabilities of fundus diseases are seriously unbalanced. There are more than 47,000 ophthalmologists in my country, but less than 5,000 are actually engaged in fundus diseases, and most of them are concentrated in large hospitals.
It can be seen from this that it is imminent to help ophthalmologists to learn and grow themselves and to promote standardized diagnosis and treatment of ophthalmic diseases. Continuing to pay attention to the “Medical Ophthalmology Channel” can help ophthalmologists obtain the latest and hottest diagnosis and treatment information and guidelines, and understand the most practical and dry diagnosis and treatment experience.
Together with the medical community, what eye diseases are you concerned about?
The full name of Ophthalmology is “Ophthalmology”, which is the study of diseases that occur in the visual system, including the eyeball and its associated tissues. Ophthalmology generally studies vitreous and retinal diseases, optometry, glaucoma and optic neuropathy, cataract and other ophthalmic diseases.
Common eye diseases are: central serous retinopathy, dry eye, sympathetic ophthalmia, night blindness, blindness, amblyopia, astigmatism, trachoma, cataract, diabetic retinopathy, conjunctivitis, Presbyopia, color blindness, heterochromia iris, retinitis pigmentosa, central retinal artery occlusion, retinal detachment, myopia, hyperopia, pin eye, snow blindness, chalazion, glaucoma, floaters, etc.
According to the scope of treatment of ophthalmic diseases, it can be divided into the following directions:
At the same time, the main categories of ophthalmic drugs in my country are concentrated in the three major areas of fundus vascular disease, anti-infection and anti-inflammatory, involving eye drops, injections, gels, tablets, capsules Five types of dosage forms.
In future tweets, the Medical Ophthalmology Channel will also work with fans and friends to continue to monitor the progress of diseases and drugs.
This article was first published: Medical Ophthalmology Channel
Editor of this article: Orange
The medical community strives for the accuracy and reliability of its published content when it is reviewed and approved, but does not make any guarantees about the timeliness of the published content, and the accuracy and completeness of the cited materials (if any), etc. Any commitments and guarantees, and do not assume any responsibility due to the outdated content, the possible inaccuracy or incompleteness of the cited information. Relevant parties are requested to check separately when adopting or using it as a basis for decision-making.